$5.46
1.11% day before yesterday
Nasdaq, Jun 28, 10:19 pm CET
ISIN
US7995661045
Symbol
SANA
Sector
Industry

Sana Biotechnology Inc Share price

$5.46
-2.34 30.00% 1M
+1.11 25.52% 6M
+1.38 33.82% YTD
-0.80 12.78% 1Y
-13.60 71.35% 3Y
-29.64 84.44% 5Y
-29.64 84.44% 10Y
Nasdaq, Closing price Fri, Jun 28 2024
ISIN
US7995661045
Symbol
SANA
Sector
Industry

Key figures

Market capitalization $1.21b
Enterprise Value $1.00b
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 3.22
Turnover (TTM) Turnover $0.00
EBIT (operating result TTM) EBIT $-332.16m
Free cash flow (TTM) Free cash flow $-273.64m
Cash position $314.91m
EPS (TTM) EPS $-1.53
P/E ratio expected negative
Short interest 22.98%
Show more

Is Sana Biotechnology Inc a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,953 shares worldwide.

Sana Biotechnology Inc Share analysis

Unlock scores for free

Analyst opinions

6 Analysts have issued a Sana Biotechnology Inc forecast:

4x Buy
67%
2x Hold
33%

Analyst opinions

6 Analysts have issued a Sana Biotechnology Inc forecast:

Buy
67%
Hold
33%

Financial data from Sana Biotechnology Inc

Profit and loss account P&L | Balance sheet | Cash flow


Quarter TTM Annually
Mar '24
+/-
%
- -
-
100%
- Direct costs 24 24
10% 10%
-
-24 -24
10% 10%
-
- Selling and administrative expenses 41 41
14% 14%
-
- Research and development costs 244 244
2% 2%
-
-309 -309
1% 1%
-
- Depreciation and amortization 24 24
10% 10%
-
EBIT (operating result) EBIT -332 -332
2% 2%
-
Net profit -309 -309
4% 4%
-

Figures in millions USD.

Don't miss a thing! We will send you all news about the Sana Biotechnology Inc share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

Sana Biotechnology Inc Share News

Neutral
InvestorPlace
about 2 months ago
Sana Biotechnology (NASDAQ: SANA ) just reported results for the first quarter of 2024. Sana Biotechnology reported earnings per share of -32 cents.
Neutral
GlobeNewsWire
about 2 months ago
SEATTLE, May 06, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at three investor conferences in May and June. The presentations will feature a business overview and update.
Positive
Invezz
2 months ago
Biotech stocks are having a relatively strong year as investors focus on the growing M&A in the healthcare space. Johnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO organization.
More Sana Biotechnology Inc News

Company profile

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.

Head office United States
CEO Steven Harr
Employees 328
Founded 2018
Website www.sana.com

Register for free

StocksGuide is the tool for easily finding, analyzing and monitoring shares. Learn from successful investors and make well-founded investment decisions. We make you a self-determined investor.

The Apple share at a glance with charts, current key figures, news and share analyses.
The best dividend stocks in the dividend top scorer list.
Stock analyses of the best stocks worldwide.
Build wealth now